Evidence map›Paper›PMID 36608681›Full record

ArticleAmerican journal of human genetics2023

Bi-allelic variants in NAE1 cause intellectual disability, ischiopubic hypoplasia, stress-mediated lymphopenia and neurodegeneration.

Irena J J Muffels, Imre F Schene, Holger Rehmann, Maarten P G Massink, Maria M van der Wal, Corinna Bauder, Martha Labeur, Natalia G Armando, Maarten H Lequin, Michiel L Houben and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 4 countries.

Irena J J MuffelsDepartment of Metabolic Diseases, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands; Center for Translational Immunology (CTI), Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Imre F ScheneDepartment of Metabolic Diseases, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands.
Holger RehmannDepartment of Energy and Biotechnology, Flensburg University of Applied Sciences, Flensburg, Germany.
Maarten P G MassinkDepartment of Genetics, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Maria M van der WalCenter for Translational Immunology (CTI), Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Corinna BauderDepartment of Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany; Institute of Developmental Genetics, Helmholtz Zentrum München, Munich, Germany.
Martha LabeurDepartment of Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany.
Natalia G ArmandoInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA) - CONICET - Partner Institute of the Max Planck Society, Buenos Aires, Argentina.
Maarten H LequinDivision Imaging and Oncology University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Michiel L HoubenDepartment of General Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Jaques C GiltayDepartment of Genetics, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Saskia HaitjemaCentral Diagnostics Laboratory, University Medical Center Utrecht, Utrecht, the Netherlands.
Albert HuismanCentral Diagnostics Laboratory, University Medical Center Utrecht, Utrecht, the Netherlands.
Fleur VansenneDepartment of Medical Genetics, University Medical Center Groningen, Groningen, the Netherlands.
Judith BluvsteinDravet Center and Comprehensive Epilepsy Center, NYU School of Medicine, New York, NY, USA.
John PappasNYU Clinical Genetic Services, NYU Grossman School of Medicine, New York, NY, USA.
Lala V ShaileeDepartment of Radiology, NYU Grossman School of Medicine, New York, NY, USA.
Yuri A ZarateSection of Genetics and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Michal MokryLaboratory of Experimental Cardiology, Department of Cardiology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
Gijs W van HaaftenDepartment of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
Edward E S NieuwenhuisDepartment of Biomedical and Life Sciences, University College Roosevelt, Middelburg, the Netherlands.
Damian RefojoInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA) - CONICET - Partner Institute of the Max Planck Society, Buenos Aires, Argentina; Molecular Neurobiology, Max Planck Institute of Psychiatry, Munich, Germany.
Femke van WijkDepartment of Genetics, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Sabine A FuchsDepartment of Metabolic Diseases, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands.
Peter M van HasseltDepartment of Metabolic Diseases, Division Pediatrics, Wilhelmina Children's Hospital University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands. Electronic address: p.vanhasselt@umcutrecht.nl.
Utrecht University · NLUniversity Medical Center Utrecht · NLMax Planck Institute of Psychiatry · DEBiomedicine Research Institute of Buenos Aires - CONICET - Partner Institute of the Max Planck Society · ARFlensburg University of Applied Sciences · DEHelmholtz Zentrum München · DENew York University · USRoosevelt Institute for American Studies · NLUniversity Medical Center Groningen · NLUniversity of Arkansas for Medical Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neddylation has been implicated in various cellular pathways and in the pathophysiology of numerous diseases. We identified four individuals with bi-allelic variants in NAE1, which encodes the neddylation E1 enzyme. Pathogenicity was supported by decreased NAE1 abundance and overlapping clinical and cellular phenotypes. To delineate how cellular consequences of NAE1 deficiency would lead to the clinical phenotype, we focused primarily on the rarest phenotypic features, based on the assumption that these would best reflect the pathophysiology at stake. Two of the rarest features, neuronal loss and lymphopenia worsening during infections, suggest that NAE1 is required during cellular stress caused by infections to protect against cell death. In support, we found that stressing the proteasome system with MG132-requiring upregulation of neddylation to restore proteasomal function and proteasomal stress-led to increased cell death in fibroblasts of individuals with NAE1 genetic variants. Additionally, we found decreased lymphocyte counts after CD3/CD28 stimulation and decreased NF-κB translocation in individuals with NAE1 variants. The rarest phenotypic feature-delayed closure of the ischiopubic rami-correlated with significant downregulation of RUN2X and SOX9 expression in transcriptomic data of fibroblasts. Both genes are involved in the pathophysiology of ischiopubic hypoplasia. Thus, we show that NAE1 plays a major role in (skeletal) development and cellular homeostasis during stress. Our approach suggests that a focus on rare phenotypic features is able to provide significant pathophysiological insights in diseases caused by mutations in genes with pleiotropic effects.

Indexed as

Intellectual DisabilityLymphopeniaHumansNEDD8 ProteinNF-kappa BProteasome Endopeptidase ComplexSignal TransductionNEDD8 ProteinNF-kappa BProteasome Endopeptidase ComplexlymphopeniaNAE1neddylationneurodegenerationocurrence ratiophenotypic specificitypost-translational protein modificationproteasomeubiquitination

Identifiers

PMID36608681
PMCPMC9892777
OpenAlexW4313557852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.